Chlorantraniliprole 97% TC quality control is a lot-release and formulation-fit decision, not a single assay result. A technical material (TC) may meet a nominal purity target and still create risk through an unclear assay basis, an incomplete impurity profile, variable physical form, or documentation that cannot support registration. Formulators, importers, and registration holders therefore need a control system covering identity, assay, impurities, physical properties, process compatibility, resistance stewardship, and traceability.
Chlorantraniliprole is an anthranilic diamide insecticide classified by the Insecticide Resistance Action Committee (IRAC) in Group 28, the ryanodine receptor modulators. The classification is relevant to product stewardship and label design, but it does not establish a universal application rate, crop claim, residue limit, or legal approval. Those requirements remain jurisdiction-specific. The Red Sun product page is a supplier reference; an importing organisation still needs to confirm the current specification, safety documentation, and registration position for the destination market.
“97% TC” describes a technical concentrate or technical material with an assay around the stated active-ingredient level. The abbreviation should not be treated as a complete quality specification. A purchasing document should identify chlorantraniliprole by the agreed chemical identity, CAS reference, assay expression, analytical method, impurity limits, physical-property requirements, packaging, and storage conditions. The specification should also state whether the assay is reported on an as-is basis or on a dry basis. Without that distinction, moisture or volatile content can make two apparently different results difficult to compare.
Identity confirmation normally combines a chromatographic comparison with an orthogonal technique such as infrared spectroscopy or mass spectrometry. The exact identity package depends on the registration dossier and laboratory capability. A supplier CoA that reports only “purity 97%” does not demonstrate identity, nor does it explain whether related substances were separated from the active peak.
Control element | What the formulator should confirm | Why it matters |
Identity | Declared active, CAS reference, batch traceability, and a matching reference standard | Prevents substitution or misidentification |
Assay | Result, basis, method, uncertainty or repeatability, and specification limit | Supports active loading and mass balance |
Related substances | Named or grouped impurities, reporting threshold, and chromatographic profile | Controls toxicological and registration uncertainty |
Physical form | Appearance, particle behavior, solid-state observations, and storage condition | Influences milling, suspension, and handling |
Documentation | CoA, SDS, batch record or traceability statement, and change-control notice | Links the shipment to an auditable supply system |
Assay is the first quantitative screen, but the result is meaningful only when the method is defined. High-performance liquid chromatography (HPLC) with a suitable detector is commonly used for active-ingredient determination in pesticide quality control. The method should define sample preparation, reference-standard assignment, chromatographic separation, detection, calculation, and system-suitability criteria. A laboratory should verify that likely process impurities and degradation products do not co-elute with chlorantraniliprole.
For supplier qualification, an independent laboratory can compare a retained sample with the supplier result. The comparison should use the same reporting basis and a method demonstrated to be fit for purpose. A difference between two results does not automatically prove a defective lot; it may reflect standard potency, water correction, sample heterogeneity, integration rules, or method selectivity. A predefined investigation pathway is more reliable than an informal pass/fail decision.
· Batch number, production date, sample date, and sample location.
· Reference standard identity, assigned potency, expiry or requalification status.
· Chromatogram or data-integrity record sufficient for an authorised reviewer.
· Method version, system suitability, replicate results, and calculation basis.
· Confirmation that the reported value is active assay rather than total chromatographic area.
The 97% value should therefore be used as a specification target agreed by the dossier owner and supplier, not as a universal regulatory limit. A lower or higher value may be acceptable in a particular process only when the technical rationale, mass balance, impurity assessment, and registration file support that decision.
Impurities can arise from unreacted intermediates, side reactions, isomeric material, catalysts, solvents, thermal stress, or storage degradation. Their importance is not determined only by concentration. A minor component may affect toxicological assessment, environmental fate, colour, odour, crystallisation, or formulation stability. The 2024 peer-reviewed study by Kannoujia and colleagues used HPLC-PDA and LC-MS/MS to identify major impurities in a commercial chlorantraniliprole sample. The study demonstrates why a single total-purity figure is insufficient for advanced supplier qualification; it does not establish a universal impurity limit for every technical material.
An impurity method should be capable of separating the active from relevant related substances. Where standards are unavailable, a laboratory may use relative response factors or area-based reporting, but the approach must be documented and justified. Unknown peaks should not be silently folded into the active assay. A trend chart across several lots is often more informative than one isolated CoA because it shows whether a process is stable or drifting.
Impurity review should connect with toxicology and regulatory assessment. If a new peak appears after a process change, the supplier should provide a change-control explanation and, where required, structural identification. A formulator should not assume that a visually acceptable technical material is suitable for all markets.
Technical material quality also has a physical dimension. Particle-size distribution, crystal habit, polymorphic form, bulk density, flowability, and hygroscopic behavior can influence milling energy, dispersion time, suspension stability, and dust generation. These attributes may vary even when the chemical assay remains within specification. For that reason, a technical-material specification should identify which physical properties are critical to the intended formulation and which are monitored as process indicators.
Particle size is particularly relevant when a solid technical material is used to produce a suspension concentrate (SC). Coarse particles can increase milling demand and sedimentation risk; an extremely fine fraction can increase dust, surface area, and wetting demand. The suitable range is formulation-specific and should be established through development work. A generic D50 value should not be presented as a universal chlorantraniliprole requirement without a validated method and product context.
Solid-state behavior also deserves attention. Different crystal forms or changes in crystallinity can affect dissolution, suspension settling, and storage stability. Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), microscopy, or melting-range observation may be used as investigative tools. These tests are best treated as comparability and troubleshooting tools unless a registration specification explicitly makes them release tests.
Observed change | Potential process consequence | Practical investigation |
Higher coarse fraction | Longer milling time or unstable suspension | Particle-size distribution, milling curve, sediment redispersion |
New XRPD pattern or thermal event | Different dissolution or crystallisation behavior | Retained-sample comparison using XRPD/DSC |
Higher moisture | Flow, caking, hydrolysis or weighing variability | Validated water method and packaging review |
Changed bulk density | Feeder or charging inconsistency | Bulk/tapped density and equipment trial |
Chlorantraniliprole technical material may enter different formulation development routes, including SC and other registered product types. The correct route depends on solvent compatibility, particle engineering, dispersant selection, suspension rheology, packaging, and the final label. A 97% assay does not predict SC stability by itself. Formulators should conduct a staged compatibility study using representative lots rather than a single laboratory sample.
1. Confirm wetting and dispersibility in the selected aqueous system.
2. Measure particle-size change before and after accelerated storage.
3. Evaluate sedimentation, redispersibility, viscosity, pH, and pourability.
4. Check sieve residue and nozzle-screen behavior where relevant.
5. Review microbial control, preservative compatibility, and container interaction.
For an emulsifiable concentrate or another solvent-based route, the relevant risks change. Solubility, crystallisation after dilution, solvent loss, flash point, container compatibility, and worker-safety classification become central. A supplier should provide a technical dossier that allows the formulator to assess these variables, while the formulator remains responsible for validation of the finished product.
IRAC classifies chlorantraniliprole in Group 28, the diamides that modulate the insect ryanodine receptor. A formulation development team should preserve this identity in product stewardship documents and avoid language suggesting that repeated use of one active ingredient is a complete resistance-management programme. The IRAC Group 28 resistance-management guidelines are designed to help prevent, delay, or manage resistance; local labels and crop-specific recommendations remain controlling.
Resistance-management planning should consider the pest, crop, generation sequence, application timing, exposure frequency, and rotation or sequence with effective products from different mode-of-action groups. The diamide literature describes the risk created when valued chemistry is used repeatedly without alternative modes of action. A technical-material purchasing decision therefore connects indirectly to stewardship: consistent assay and impurity control support predictable exposure, while the label and agronomic programme determine lawful and responsible use.
Quality documentation should not make efficacy claims that are not supported by the relevant registration. Statements about target pests, crops, residual performance, or application intervals require local evidence and label review. International product pages can identify the active ingredient and supply capability, but they cannot replace national registration.
A CoA is a lot-specific record, not a substitute for a quality agreement. Sampling should be representative of the shipment and consistent with a written plan. The plan should define the number of containers, sampling equipment, composite-sample rules, sample retention, chain of custody, and conditions that could bias results. For a technical powder, segregation and moisture gradients can make a top-layer grab sample unrepresentative.
Out-of-specification (OOS) results need a documented investigation. An analyst or laboratory error should be assessed first, but the investigation should not end with an invalidated result unless the evidence supports that conclusion. The supplier, importer, and testing laboratory should agree on notification timing, confirmatory testing, disposition, and corrective action. Repeated borderline results may indicate a process trend even when no single lot is formally OOS.
Decision | Minimum evidence | Disposition |
Release | Conforming assay, identity, impurity and physical checks; complete documentation | Approve for defined formulation route |
Conditional hold | One discrepant result or incomplete method evidence | Investigate; no production use before authorised release |
Reject or return | Confirmed critical impurity, identity failure, or unresolved OOS | Quarantine and follow the quality agreement |
Before commercial purchase, a registration holder should map the technical material against the destination-country dossier. The review normally includes active-ingredient identity, manufacturing source, process description, five-batch or equivalent impurity information where required, toxicology and ecotoxicology data, analytical methods, SDS, packaging, and transport classification. The exact submission requirements vary by authority and product type.
· Confirm the supplier name, manufacturing site, and source statement.
· Match the technical specification to the dossier and finished-product composition.
· Obtain current SDS, CoA template, analytical method summary, and change-control terms.
· Define inspection, sampling, retained samples, and OOS responsibilities.
· Verify that claims and labels are authorised in every intended market.
· Qualify at least one representative lot through formulation and stability trials.
Red Sun’s chlorantraniliprole product information can be used as an initial supplier reference for technical discussions. A buyer should request the current lot-specific documents and confirm that the offered grade matches the intended regulatory and formulation purpose.
No. Assay is one release attribute. Identity, relevant impurities, moisture, physical behavior, documentation, and the applicable registration specification also need review.
No. Impurity limits depend on the approved specification, analytical capability, toxicological assessment, and destination-market requirements. Peer-reviewed impurity studies support method development but do not automatically become commercial limits.
Copying a target without formulation evidence is unsuitable. Particle-size requirements depend on milling equipment, dispersants, solids loading, storage, and application hardware.
No. The classification supports resistance-management communication. Crop, pest, dose, interval, and rotation requirements are determined by the local label and validated agronomic guidance.
A quality and change-control package is often most useful because it connects the lot result to the method, manufacturing source, retained sample, notification process, and corrective-action responsibilities.
Chlorantraniliprole 97% TC quality control is strongest when chemical identity, assay, impurity profiling, physical properties, formulation performance, resistance stewardship, and regulatory traceability are reviewed as one decision. A clear specification and representative sampling programme reduce avoidable surprises, while independent confirmation and OOS procedures protect the importing organisation. Supplier discussions can begin with the chlorantraniliprole technical material reference and the broader agrochemical active ingredient range, followed by dossier-specific qualification before production or registration use.
